News

[Press Alert] Omicron Variant : positive results for XENOTHERA's XAV-19 antibody

# Download our press information (english version) # Télécharger notre communiqué de...

More

[Press information] XENOTHERA announces the continuation of development of its anti-SARS-CoV-2 antibody.

January 2022. # Download our press information (english version) # Télécharger notre...

More

[ Press Information ]The French biotech XENOTHERA awarded Start-Up of the Year for the Western region.

# Download our press information (english version) # Télécharger notre information presse...

More

[Newsletter] XENONEWS

October 2021 >> Official XENOTHERA’s newsletter /Lettre d’information officielle de XENOTHERA <<...

More

[Newsletter] XENONEWS

Summer 2021. >> Official XENOTHERA newsletter /Lettre d’information officielle de XENOTHERA <<...

More

[Press Alert] XENOTHERA signs a pre-order contract of its anti-covid treatment with the French government

May 11, 2021. # Download our press information (english version) # Télécharger...

More

[Newsletter] XENONEWS

May 2021 >> Official XENOTHERA newsletter /Lettre d’information officielle de XENOTHERA <<...

More